Attorneys See Growth in Lawsuits Over Eye Disease Drug Tepezza |

An infusion drug that treats a rare disease has caught the eye of lawyers, who have filed over a dozen cases with more expected in the months ahead.

The drug, Tepezza, which the U.S. Food and Drug Administration approved in 2020, treats thyroid eye disease through intravenous infusions.

Source link

Leave a Comment